https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1495965/full
Frontiers | Efficacy and safety of Lemborexant in treating adult patients with insomnia in China: a...
BackgroundExcept for one case report, there has been no published study of Lemborexant treatment for patients with insomnia in China. This study investigated...
https://pmc.ncbi.nlm.nih.gov/articles/PMC10835435/
Transitioning insomnia patients from zolpidem to lemborexant: A multicenter, open-label study...
Few clinical studies have assessed real-world abrupt transitioning between insomnia medications. This study assessed strategies for directly transitioning...
https://www.aafp.org/pubs/afp/issues/2021/0215/p241.html
Lemborexant (Dayvigo) for the Treatment of Insomnia | AAFP
Lemborexant (Davigo) is labeled for adults with insomnia to improve with sleep onset and maintenance.
for thelemborexantdayvigotreatmentinsomnia
https://refractor.io/brain/alzheimers-dementia/alzheimers-hope-sleep-aid-blocks-up-to-40-more-harmful-tau-deposits/
Sleep aid lemborexant shows promise in protecting brain health
Jun 1, 2025 - Lemborexant, a sleep aid, may protect against tau buildup linked to Alzheimer's, offering new hope for neurodegenerative disease treatment.
sleep aidlemborexantshowspromiseprotecting
https://www.ncbi.nlm.nih.gov/books/NBK559070/
Lemborexant - StatPearls - NCBI Bookshelf
Lemborexant is a medication used in the management and treatment of insomnia. It is in the dual orexin antagonist class of medications. This activity outlines...
lemborexantncbibookshelf